March 12 (UPI) --Health experts say an Australian study linking sexual activity to an infection that 1 in 3 U.S. women contract has provided a new tool to prevent recurrences, as well as find a cure.

While the link between TNF inhibitor use during pregnancy/postpartum and serious infection risk was not statistically significant, an increased risk cannot be ruled out.

Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study, none of ...

Winter often triggers recurrent UTIs in women. Here's why cold weather, dehydration, delayed urination and reduced immunity ...

Bacterial vaginosis is most likely a sexually transmitted infection, according to a new study. By Alisha Haridasani Gupta Bacterial vaginosis is a poorly understood infection that affects one in three ...

A healthy 32-year-old gravida 1 para 0 at 38 4/7 weeks' gestation was admitted to labor and delivery at 5 PM in labor. Her history and prenatal course were uncomplicated. She had a negative group B ...

HIV incidence with lenacapavir was significantly lower than background HIV incidence and than HIV incidence with F/TDF. HealthDay News — For adolescent girls and young women, lenacapavir every 26 ...

Women might be more likely to develop drug-resistant infections than men — an under-recognized aspect of the growing threat of antimicrobial resistance, according to a global review led by the World ...